YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Europe and/or Bust


March 20, 2012 | Even though Europe's financial system has been on charging downhill recently, several venture firms have invested heavily in European biotech in recent months. Their argument: the science and the talent exist, and experienced executives are looking for entrepenurial opportunities. But does that really outweigh the negatives? Xconomy
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.